27 Mar 2018

ICLR 2018

Authors: Daniel Neil, Marwin Segler, Laura Guasch, Mohamed Ahmed, Dean Plumbley, Matthew Sellwood, Nathan Brown

Abstract

The essence of molecular design is to effectively fulfill a molecular property profile that is desirable as a drug. In this paper we consider a number of different generative models for the design of new molecular structures the satisfy specific multiple objectives that are desirable for a particular drug discovery project. In addition to the evaluation of multiple generative models, we also presented as part of this work a benchmarking dataset to the community with the aim to provide an objective set to evaluate other new de novo molecular design models appropriately


Back to publications

Latest publications

01 May 2024
Journal of Biomedical Semantics, volume 15, Article number: 5 (2024)
Elucidating the Semantics-Topology Trade-off for Knowledge Inference-Based Pharmacological Discovery
Read more
12 Oct 2023
Translational Neurodegeneration. 2023; 12: 47
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
Read more
09 Oct 2023
FRONTIERS IN GENETICS
Learning the kernel for rare variant genetic association test
Read more